Sacral wound dressing
Latest Bristol-Myers Squibb Company Patents:
- Substituted indole dimer compounds
- METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3
- Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)
- Substituted thienopyrroles as PAD4 inhibitors
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
Description
The broken line showing of sacral wound dressing is included for the purpose of illustrating stitching and forms a part of the claimed design.
Claims
We claim the ornamental design for the sacral wound dressing, as shown and described.
Referenced Cited
Patent History
Patent number: D607113
Type: Grant
Filed: Dec 5, 2007
Date of Patent: Dec 29, 2009
Assignee: Bristol-Myers Squibb Company (Skillman, NJ)
Inventors: Jan Rogers (Flintshire), Bryony Lee (Flintshire)
Primary Examiner: Holly H Baynham
Assistant Examiner: Michelle E Wilson
Attorney: John M. Kilcoyne
Application Number: 29/298,417
Type: Grant
Filed: Dec 5, 2007
Date of Patent: Dec 29, 2009
Assignee: Bristol-Myers Squibb Company (Skillman, NJ)
Inventors: Jan Rogers (Flintshire), Bryony Lee (Flintshire)
Primary Examiner: Holly H Baynham
Assistant Examiner: Michelle E Wilson
Attorney: John M. Kilcoyne
Application Number: 29/298,417
Classifications
Current U.S. Class:
Bandage For Protection Or Treatment (53) (D24/189)